Antihuman epidermal growth factor receptor 2 (HER2) monoclonal antibody trastuzumab enhances cytolytic activity of class I-restricted HER2-specific T lymphocytes against HER2-overexpressing tumor cells
(Q77948519)
scientific article published on 01 April 2002
scientific article published on 01 April 2002
Language: